GSI Lumonics Sells Life Sciences Businessto Packard BioScience
KANATA, Ontario, Canada, Aug. 22 -- GSI Lumonics Inc., supplier of laser-based automated advanced manufacturing systems and services to industrial companies, has sold its Life Sciences business to Packard BioScience Co. Packard BioScience will obtain the operating assets related to GSI's Life Sciences business for a combination of cash and stock valued at about $120 million (US) upon standard regulatory approvals. The companies will close the deal by the end of the third quarter, said GSI Lumonics.
GSI Lumonics' Life Sciences unit makes software-controlled confocal scanning systems for the analysis of fluorescently labeled microarray biochips under the ScanArray and QuantArray trade names. The products are used for gene expression, genotyping, mapping, high-throughput screening and drug discovery. GSI's Life Sciences unit represents approximately 5 percent of the company's sales.
Packard BioScience is located in Meriden, Conn., where it provides instruments and services used in the life sciences research and nuclear industries.
LATEST NEWS
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024
- One-Step Hologram Generation Speeds 3D Display Creation
Apr 24, 2024
- Innovation Award Winners for Laser Technology Honored in Aachen
Apr 23, 2024
- Intech 2024: AI Arrives on the Shop Floor
Apr 22, 2024